Drug Shortage Report for ZARONTIN
| Report ID | 172389 |
| Drug Identification Number | 00022799 |
| Brand name | ZARONTIN CAP 250MG |
| Common or Proper name | ZARONTIN CAP |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ETHOSUXIMIDE |
| Strength(s) | 250MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | BOTTLE 100'S |
| ATC code | N03AD |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-10-06 |
| Actual start date | 2022-10-07 |
| Estimated end date | 2023-02-15 |
| Actual end date | 2023-02-01 |
| Shortage status | Resolved |
| Updated date | 2023-02-02 |
| Company comments | RESOLVED |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2022-10-21 | French | Compare |
| v1 | 2022-10-21 | English | Compare |